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Summary: Diagnostic judgement is usually based on recognition of patterns. Unfortunately more than three
quantitative data cannot be judged simultaneously without help of mathematical methods. Working on
laboratory reports, a clinician usually goes linearly through the columns and reduces quantitative to qualitative
data. Therefore the medical decision process should be improved if data reduction is performed with the aid
of mathematical methods for pattern recognition.
A total of 191 consecutive outpatients with a tentative or proven diagnosis of hepatobiliary disease were
examined clinically, clinically chemically and partly histologically. Nineteen clinical chemical parameters were
determined. Prior to pattern cognition, a principal component analysis was performed. Using six factors,
accounting for 72.4% of total variance, cluster analysis was done, applying a hierarchical algorithm for
ascertaining a starting partition, followed by the k-means algorithm. The validity of the solution was
scrutinized, and a stable structure was found with nine clusters. Patients with a rejected suspect of liver disease
were mainly located in clusters 1, 6 and 7. Cluster 1 also contains patients with compensated cirrhosis without
inflammation, idiopathic hyperbilirubinaemia, focal nodular hyperplasia and haemangioma of the liver. In
contrast, one third of cirrhoses, all with inflammatory activity were assigned to cluster 5. Patients with primary
biliary disease were distributed among clusters 2, 3 and 4. All malignant neoplasias were assigned to cluster
9. More than 50% of fatty livers were classified to cluster 7. Cluster 2 and 8 contain only one patient with
primary biliary cirrhosis (cluster 2) and fatty liver hepatitis (cluster 8). The follow-up of 66 patients also
showed clinically meaningful changes of cluster assignment.
Introduction . . . . -*u r · ι i_ - 1viding the clinician with clinical chemical patterns
Diagnostic judgment in hepatobiliary diseases is often instead of a lot of single data.
necessarily based on a large battery of laboratory _ _ , ^ Λ r Λ ι -^ „ . « · . i ^ r i u Many attempts have been made to find multivanatetests. But with an increasing number ot laboratory _ , A ^ , . ,. , , . .t , . concepts (for example 1—4) which should supportresults it becomes more and more impossible to take , t: . . . t . . r ,. . , « . ,, . « · " i t the clinician in the interpretation of clinical chemicalinto account interrelationships between the parame- _, ^ , - , ι , , r · *, * . * u · * ·*· T-U r u r data. Commonly used methods, however, of inter-ters observed just by intuition. Therefore the use of . ,. . , * · t ·, / , -,· · ·« 1 t . υ , i i r - i - pretmg clinical chemical data (such as discriminantiormal abstract operations could be helpful m pro- , . N , , , , , ,analysis) have the drawback that they require a cor-
— —— rect final diagnosis made independently of the clinical
This publication is part of thesis of U. R chemical data.
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In our opinion a suitable model for a diagnostic
support should meet two requirements:
— to avoid the above-mentioned drawback, the pro-
cedure should be independent of the diagnoses
and
— the information from a patient's data should be
condensed to one total unit of information to
facilitate the interpretation of the data.
A more detailed discussion of this problem can be
found in 1. c. (8).
Several previous publications of our group (5 — 8)
dealt with cluster analysis for defining groups of pa-
tients with similar patterns of clinical chemical data.
The model based on these results and constructed
with patients suffering from thyroid diseases was
found to be a meaningful method of data reduction
in clinical chemistry, clinically helpful and suitable for
increasing diagnostic information.
Readers who are interested in a more comprehensive
discussion of pattern cognition and recognition in
clinical chemistry are referred to 1. c. (8).
In the present study patients suspected of having liver
disease were classified by cluster analysis using clinical
chemical parameters only. The biochemical entities
were determined absolutely independently of premises
such as symptoms, signs or diagnoses. An important
question was whether it would be possible to find a
stable classification in spite of the large number of
laboratory tests used, and furthermore whether the
grouping would be clinically meaningful.
Materials and Methods
Acquisi t ion of data
All 191 outpatients, referred to an expert hepatologist2) during
an 18-month period with a tentative diagnosis of hepatobiliary
disease or follow-up of known liver disease, were included in
the present study. They all were examined by the same expert.
If necessary, the liver was histologically examined by needle
biopsy.
Nineteen clinical chemical parameters were determined quan-
titatively in each patient (cf. fig. 2). Based on these parameters
and all the clinical information, the hepatologist made a final
diagnosis for each patient. The case history and the findings of
the physical examination were listed in a standardized protocol.
Laboratory data were stored and processed without knowledge
of clinical data.
Principal component analysis and cluster analysis
The 19 clinical chemical parameters were standardized to zero
mean and unit variance, then a principal component analysis
2) Prof. Dr. Josef Eisenburg, formerly a member of the medical
staff of the Medizin. Klinik II, Klinikum Grosshadern, has
taken the clinical part and provided us with diagnoses. We
are greatfully indebted for his kind support.
was performed. The resulting six main components were used
as variables for classification. Each patient was represented as
a point in a six dimensional space.
As a partitioning clustering method we chose the variance
criterion, which minimizes the variances within each group. The
algorithm we used is known as the k-means principle (9). For
obtaining a preoptimized starting partition we used the hier-
archical clustering method of Ward (10), which optimizes the
same criterion. The choice of these methods implies the use of
Euclidean distances. The "right" number of clusters was deter-
mined by using the concept of cluster validity (8).
Hardware and programs
All programs were run on a Siemens P 7.570. For principal
component analysis program BMDP4M was used. For cluster
analysis we used the algorithms by Späth (9), while all other
programs were written by us.
Results and Discussion
Certain problems are involved in applying numerical
classification procedures, because cluster analysis in-
cludes a broad spectrum of mostly empirical methods
that lack commonly accepted recommendations for
deciding the following questions.
Choice of clinical chemical parameters
The first problem to be solved was the selection of
the kind and number of clinical chemical parameters.
Obviously the choice of variables used to describe a
patient has great influence on the result of classifi-
cation. We had to carefully consider medical and
mathematical aspects. Thus, the aim of the present
study was to support the clinician in differential di-
agnosis of diseases of the liver, and since this is a
most complex organ with many biochemical func-
tions, the application of a large number of clinical
chemical parameters seemed to be necessary. Since
there are many partly contradictory recommendations
for using laboratory tests in hepatology, we selected
a combination of 19 quantitative parameters, which,
nevertheless, are probably not considered the best by
everyone.
Principal component analysis
From a mathematical point of view the medically
motivated use of 19 variables for clustering a sample
of 191 patients is not practicable, as the distribution
of the patients in a 19-dimensional space would be
too rarefied, i. e. a stable classification is improbable.
Further, the unwanted, strong influence of linearly
dependent parameters on the classification result
needs to be diminished.
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Therefore we decided on a principal component anal- analysis, we dispensed with trying a pathophysiolog-
ysis with the patients' data. As the method was re- ical interpretation of the principal components. The
quired only for data reduction before using cluster criterion for limiting the number of principal com-
ponents was to extract only components with eigen-
values > 1. The six components determined by this
method accounted for 72.36% of the total variance
of the clinical chemical parameters. The sequence of
the factors 1 — 6 is arranged in decreasing order of
variance represented by each factor (fig. 1). Figure 2
shows which proportion of variance of the 19 clinical
1 2 3 4 5 6 ( 7 - 1 9 ) chemical parameters is explained by the six compo-
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Fig. 2. Variances of the 19 clinical chemical parameters explained by factors 1—6.
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nents extracted and which part is not taken into
account. As there is a quota of variance that is inexpli-
cable by six factors only (uniqueness), the principal
component scores are values which are statistically
estimated. That means a loss of information, a draw-
back which can be accepted for the sake of projecting
data from the 19-dimensional to the six-dimensional
space.
Number of clusters
Another problem is to decide on the optimal number
of clusters. In making this decision we considered two
aspects.
Firstly, from a pragmatic point of view the number
of groups depends on the medical purpose of the
study and therefore on a certain subjective decision
made by the user. The aim of the present work is to
find a model supporting the clinician in multivariate
interpretation of laboratory results concerning differ-
ential diagnosis of liver diseases. Therefore we decided
that a differentiating model with about ten or fifteen
groups would be more useful than a model with two
or three groups only. Secondly, however, the decision
should not be made on grounds of subjective consid-
erations only. A procedure recommended e. g. by 1. c.
(11) for partitioning clustering methods is to plot the
criterion value (in our case the sum of variances with-
in each group) against the number of clusters. For 2
to 25 partitions we obtained a monotonously decreas-
ing curve with local minima of the optimization func-
tion at the group numbers 4, 9, 12 and 16. The result
for group number 9 was most significant.
The problem of choosing the correct number of clus-
ters can also be solved in connection with cluster
validity. We assumed that the solution with the high-
est validity represents the true structure of the data
set in the best way. Using this concept, we have a
method for separating true cluster structures from
artefacts produced by an algorithm (7, 8).
Necessary conditions for the validity of a classifica-
tion are as follows:
1. The partition obtained will be found for different
samples of the same general population (internal
stability).
2. Small changes in the input data will produce only
small changes in classification (external stability).
Internal stability
The internal stability of different partitions was meas-
ured as follows. Half of the patients of the sample
were taken randomly and clustered in the same way
as the original data. The procedure was repeated with
35 different random samples each for the group num-
bers 2 to 25. As found in prior investigations, a
number of 35 repeats is sufficient (8). The results were
compared with the original clustering for the selected
patients. For calculating the consistency of the differ-
ent partitions we used "Rand's measure corrected for
chance" (12). Figure 3 shows the median values of
the 35 stability coefficients plotted against the group
numbers 2 to 25. In the interpretation of figure 3, not
only the absolute values have to be considered, but
above all the form of the stability curve. Considering
former results (8), it is supposed that a stability curve
created by a data set without cluster structure in-
creases nearly monotonically, so that the existence of
peaks or shoulders of a function points to solutions
with high stability. There are peaks for the group
numbers 9, 11, 18 and 19. The maximum of the curve
shows the partition of 9 clusters to be the classification
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Fig. 3. Internal stability of structure.
Taking into consideration the subjective aspects de-
scribed above and the results of the two mathematical
procedures, the optimal number of clusters is nine.
External stability
A method of proving the external stability is to assign
all the patients with input data (changed by adding
errors) to the clusters by a reclassification algorithm.
The percentage of correctly reclassified patients is a
concrete measure of the external stability of the par-
tition found; alternatively, if it is calculated for each
cluster, it is a measure of the validity of a single
group. According to the analytical imprecision of the
methods, we added 35-times random errors to the
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original data. The distribution of the errors was
known from the daily routine work. The average
reclassification rate was calculated for the total par-
tition, as well as for each single cluster.
With 82% of correct reclassification we regard the
external stability to be sufficient. Table 1 shows that
the results for the large clusters are not as good as
for those with few patients. But it is precisely for the
small groups that a good stability is very important
from a medical point of view.
Tab. 1. Matrix of relative frequency (%) of assignment by 35
reclassifications.
Group Group
the the patient is assigned to after adding analytical
patient errors











































To give a graphic presentation of the groups for each
cluster the mean value of the six variables (principal
components) Fl — F6 are shown as vectors, whose
length is a measure of the respective value. The total
means of the factors lie on the arch of a circle. So the
similarity of difference of the groups is clearly visible
by their graphic representation (fig. 4). Groups which
Fig. 4. Graphical patterns of the nine groups. Beginning from
noon in clockwise direction: factor 1, 2, 3, 4, 5, 6.
exchange many patients in consequence of fluctuating
input data show a similar graphical pattern, e. g. clus-
ters 1, 6 and 7.
The percentage of objects that have changed groups
due to imprecision of input data can be used for
showing the vicinity of and interrelations between
different clusters (fig. 5). Clusters which interchange
patients are connected with lines, the numbers above
correspond to the vicinity of two clusters given by the
average erroneous reclassification rate of a group Gi
to a group Gj and vice versa.
Clinical in terpreta t ion of the clusters found
For checking the clinical meaning of the entities de-
rived only from laboratory data, we compared the
clinical chemical classification with the final diagnoses
(which are partly based on morphological criteria)
and with clinical findings.
It is self-evident that we had not expected to find an
exact consistency between a classification based solely
on laboratory tests and a classification based mainly
on morphological criteria. We also did not intend to
replace the previous nosological system by a clinical
chemical classification like the present model or to
anticipate any kind of diagnosis. But the model is
only useful for the clinician if there is some connection
between the grouping found and the current diagnos-
tic concepts. We succeeded in finding a relation be-
tween the two kinds of classification.
Tables 2 and 3 show the final diagnoses for the sample
and their distribution among the clusters. Patients, in
which the suspect of liver disease could be rejected,
were mainly allocated to cluster 1 (71.4%), to cluster
6 (11.4%) and cluster 7 (14.3%). Cluster 1 also con-
tains the patients with diagnosis of idiopathic hyper-
bilirubinaemia, focal nodular hyperplasia and hae-
mangioma of liver. Twenty five percent of the patients
diagnosed as having cirrhosis are classified in cluster
1. These cirrhoses are all well compensated and with-
out inflammatory activity. In contrast to this, the
30% of cirrhoses representing the main part of cluster
5 show inflammatory activity, reduced liver function
and a history of repeated decompensation. The pa-
tients originally given the diagnosis of primary biliary
disease are distributed among clusters 2, 3 and 4. All
cases of malignant neoplasia (liver cell carcinoma and
liver metastases) are assigned to cluster 9. More than
half of the patients with steatosis are classified in
cluster 7. The two singular groups (2 and 8) each
contain a single patient with an extreme form of
disease.
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Chronic active hepatitis without cir-
rhotic transformation
Acute viral hepatitis with prolonged
course
Primary biliary cirrhosis






State after partial resection of the













































It is evident from table 3 that all non-singular clusters
contain patients of different diagnostic categories,
which means that an exact correspondence of the two
classifications does not exist. Certainly the main rea-
son for the discrepancy is neither a failure of clustering
methods nor an accumulation of diagnostic errors,
but the impossibility of completely separating the
disease groups by means of clinical chemistry only.
Therefore the model does not provide the clinician
with a new concept of diseases or with an improved
form of the previous concept. But information on the
cluster membership of patients provides the clinician
with clinical chemical patterns instead of a mass of
values. An experienced clinician is accusturned to
work with patterns by evaluating symptoms and signs,
and anamnestic or histologic findings. There should
therefore be little difficulty in working with laboratory
patterns defined by mathematical procedures.
There exists a graphically presentable individual fig-
ure for every patient, which can be compared with
the figure of the group the patient has been assigned
to and with the figures of other groups. In our ex-
perience, the monitoring of laboratory results in the
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course of a disease is facilitated if the physician can repeatedly at different times, showed that changes in
watch the development of a pattern instead of looking diagnosis or in therapy are often correlated with
for changes of single parameters. change of the assigned cluster. By means of two
representative cases, figure 6 demonstrates that the
Observations in 66 patients, who had been examined, application of the model could be a useful tool in

















Patient 1 suffered from a HBsAg and HBeAg positive chronic active hepatitis with cirrhosis, severe portal hypertension,
splenomegaly and with history of ascites, gastrointestinal bleeding and encephalopathy and was assigned to cluster 5 at the point
of admission. During a period of 67 weeks of supervision seroconversion from HBeAG pos to neg occurred, followed by










Patient 2 had suffered from steatosis of liver for some years. At admission he was assigned to cluster 7. At the following
examination an acute A hepatitis was diagnosed. From the results of the same date the patient was allocated to cluster 8, showing
an impressive clinical chemical pattern. Some weeks later he returned to the group he had been attached to at the first examination.
Fig. 6. Cluster membership of patients during the course of disease.
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It should be mentioned that the model is based on a
certain data base and is only valid for this in a strict
sense.
In conclusion, the application of cluster analysis based
on clinical chemical parameters leads to a clinically
meaningful classification of patients with liver dis-
eases.
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